Xiongwen Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiongwen Lv has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Fei Wang
Department of Burns The First Affiliated Hospital of Anhui Medical University Hefei Anhui China
5 shared publicationsSheng Liu
Department of Burns The First Affiliated Hospital of Anhui Medical University Hefei Anhui China
5 shared publicationsSheng Wang
Department of Pharmacy, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital of Wannan Medical College, Wuhu, China
5 shared publications- Jiajie Luan
Department of Pharmacy, Yijishan Affiliated Hospital of Wannan Medical College, Wuhu, Anhui Province, China
4 shared publications Le Qiu
Department of Burns The First Affiliated Hospital of Anhui Medical University Hefei Anhui China
3 shared publicationsSongsen Gao
Department of Pharmacy, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital of Wannan Medical College, Wuhu, China
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Springer Nature in BMC Plant Biology
Chloroplast ycf1-based DNA barcode enables authentication of Chrysanthemum morifolium and C. indicum and detects adulteration in their herbal products
Chrysanthemum morifolium and C. indicum are globally renowned for their health-promoting properties and are widely used in herbal medicine. Moreover, they have been increasingly used in the food industry, particularly in the herbal tea sector. However, accurately identifying these two herbal medicines at the molecular level remains challenging. In this study, a highly specific and novel DNA barcode, ycf1 , was developed through comparative chloroplast genome analysis. Molecular authentication of 80 commercial herbal tea products revealed the following: (1) The ycf1 DNA barcode distinguished C. morifolium (Cm-Type) from C. indicum (Ci-Types I-III), while also distinguishing their admixtures, demonstrating authentication ability for species authentication. (2) Among 40 C. morifolium herbal tea products, 85% were authentic, whereas the remaining were adulterated with C. indicum . (3) For 40 C. indicum herbal tea products, 62.5% were authentic, whereas the remaining were adulterated with C. morifolium or Artemisia sieversiana . This study establishes the chloroplast ycf1 barcode as a high-resolution molecular tool for authenticating Chrysanthemum species, demonstrating its dual utility in: discrimination of pure and mixed samples, and detection of adulterants in commercial herbal teas. These advancements significantly improve quality control protocols for herbal products and provide a reference basis to strengthen regulatory oversight in the medicine-food homology industry.
- 6 November 2026
- Published by Springer Nature in BMC Plant Biology
Open AccessChloroplast ycf1-based DNA barcode enables authentication of Chrysanthemum morifolium and C. indicum and detects adulteration in their herbal products
Chrysanthemum morifolium and C. indicum are globally renowned for their health-promoting properties and are widely used in herbal medicine. Moreover, they have been increasingly used in the food industry, particularly in the herbal tea sector. However, accurately identifying these two herbal medicines at the molecular level remains challenging. In this study, a highly specific and novel DNA barcode, ycf1 , was developed through comparative chloroplast genome analysis. Molecular authentication of 80 commercial herbal tea products revealed the following: (1) The ycf1 DNA barcode distinguished C. morifolium (Cm-Type) from C. indicum (Ci-Types I-III), while also distinguishing their admixtures, demonstrating authentication ability for species authentication. (2) Among 40 C. morifolium herbal tea products, 85% were authentic, whereas the remaining were adulterated with C. indicum . (3) For 40 C. indicum herbal tea products, 62.5% were authentic, whereas the remaining were adulterated with C. morifolium or Artemisia sieversiana . This study establishes the chloroplast ycf1 barcode as a high-resolution molecular tool for authenticating Chrysanthemum species, demonstrating its dual utility in: discrimination of pure and mixed samples, and detection of adulterants in commercial herbal teas. These advancements significantly improve quality control protocols for herbal products and provide a reference basis to strengthen regulatory oversight in the medicine-food homology industry.
- Open Access
- 29 June 2023
- Published by Wiley in International Wound Journal
- Vol. 20 (9) , 3708-3716
Diagnostic value of procalcitonin and red blood cell distribution width at admission on the prognosis of patients with severe burns: A retrospective analysis
The plasma procalcitonin (PCT) concentration and red blood cell distribution (RDW) value after severe burns can be used as prognostic indicators, but at present, it is difficult to give consideration to sensitivity and specificity in diagnosing the prognosis of severe burns with a single indicator. This study analysed the diagnostic value of plasma PCT concentration and RDW value at admission on the prognosis of severe burn patients to improve its sensitivity and specificity. A total of 205 patients with severe burns who were treated in the First Affiliated Hospital of Anhui Medical University from November 2017 to November 2022 were retrospectively analysed. The optimal cut‐off values of plasma PCT concentration and RDW were analysed and counted through the subject curve (ROC curve). According to the cut‐off value, patients were divided into high PCT group and low PCT group, high RDW group and low RDW group. The independent risk factors of severe burns were analysed by single‐factor and multiple‐factor COX regression. Kaplan–Meier survival was used to analyse the mortality of high PCT group and low PCT group, high RDW group and low RDW group. The area under the curve of plasma PCT concentration and RDW value at admission was 0.761 (95% CI, 0.662–0.860, P < .001), 0.687 (95% CI, 0.554–0.820, P = .003) respectively, and the optimal cut‐off values of serum PCT concentration and RDW were 2.775 ng/mL and 14.55% respectively. Cox regression analysis found that age, TBSA, and RDW were independent risk factors for mortality within 90 days after severe burns. Kaplan–Meier survival analysis showed that there was a significant difference in the 90‐day mortality rate of severe burns between the PCT ≥ 2.775 ng/mL group and the PCT < 2.775 ng/mL group (log‐rank: 24.162; P < .001), with the mortality rate of 36.84% versus 5.49%, respectively. The 90‐day mortality rate of severe burns was significantly different between the RDW ≥ 14.55% group and the RDW < 14.55% group (log‐rank: 14.404; P < .001), with the mortality rate of 44% versus 12.2% respectively. The plasma PCT concentration and RDW value at admission are both of diagnostic value for the 90‐day mortality of severe burns, but the plasma PCT concentration has higher sensitivity and the RDW value has higher specificity. Age, TBSA, and RDW were independent risk factors for severe burns, and then plasma PCT concentration was not independent risk factors.
- 29 June 2023
- Published by Wiley in International Wound Journal
- Vol. 20 (9) , 3708-3716
Open AccessDiagnostic value of procalcitonin and red blood cell distribution width at admission on the prognosis of patients with severe burns: A retrospective analysis
The plasma procalcitonin (PCT) concentration and red blood cell distribution (RDW) value after severe burns can be used as prognostic indicators, but at present, it is difficult to give consideration to sensitivity and specificity in diagnosing the prognosis of severe burns with a single indicator. This study analysed the diagnostic value of plasma PCT concentration and RDW value at admission on the prognosis of severe burn patients to improve its sensitivity and specificity. A total of 205 patients with severe burns who were treated in the First Affiliated Hospital of Anhui Medical University from November 2017 to November 2022 were retrospectively analysed. The optimal cut‐off values of plasma PCT concentration and RDW were analysed and counted through the subject curve (ROC curve). According to the cut‐off value, patients were divided into high PCT group and low PCT group, high RDW group and low RDW group. The independent risk factors of severe burns were analysed by single‐factor and multiple‐factor COX regression. Kaplan–Meier survival was used to analyse the mortality of high PCT group and low PCT group, high RDW group and low RDW group. The area under the curve of plasma PCT concentration and RDW value at admission was 0.761 (95% CI, 0.662–0.860, P < .001), 0.687 (95% CI, 0.554–0.820, P = .003) respectively, and the optimal cut‐off values of serum PCT concentration and RDW were 2.775 ng/mL and 14.55% respectively. Cox regression analysis found that age, TBSA, and RDW were independent risk factors for mortality within 90 days after severe burns. Kaplan–Meier survival analysis showed that there was a significant difference in the 90‐day mortality rate of severe burns between the PCT ≥ 2.775 ng/mL group and the PCT < 2.775 ng/mL group (log‐rank: 24.162; P < .001), with the mortality rate of 36.84% versus 5.49%, respectively. The 90‐day mortality rate of severe burns was significantly different between the RDW ≥ 14.55% group and the RDW < 14.55% group (log‐rank: 14.404; P < .001), with the mortality rate of 44% versus 12.2% respectively. The plasma PCT concentration and RDW value at admission are both of diagnostic value for the 90‐day mortality of severe burns, but the plasma PCT concentration has higher sensitivity and the RDW value has higher specificity. Age, TBSA, and RDW were independent risk factors for severe burns, and then plasma PCT concentration was not independent risk factors.
- 22 February 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 107, 108641
Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver
- 22 February 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 107, 108641
Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver
- Open Access
- 27 July 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease
Chemokine receptors are members of the G protein-coupled receptor superfamily, which together with chemokine ligands form chemokine networks to regulate various cellular functions, immune and physiological processes. These receptors are closely related to cell movement and thus play a vital role in several physiological and pathological processes that require regulation of cell migration. CXCR4, one of the most intensively studied chemokine receptors, is involved in many functions in addition to immune cells recruitment and plays a pivotal role in the pathogenesis of liver disease. Aberrant CXCR4 expression pattern is related to the migration and movement of liver specific cells in liver disease through its cross-talk with a variety of significant cell signaling pathways. An in-depth understanding of CXCR4-mediated signaling pathway and its role in liver disease is critical to identifying potential therapeutic strategies. Current therapeutic strategies for liver disease mainly focus on regulating the key functions of specific cells in the liver, in which the CXCR4 pathway plays a crucial role. Multiple challenges remain to be overcome in order to more effectively target CXCR4 pathway and identify novel combination therapies with existing strategies. This review emphasizes the role of CXCR4 and its important cell signaling pathways in the pathogenesis of liver disease and summarizes the targeted therapeutic studies conducted to date.
- 27 July 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Open AccessEmerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease
Chemokine receptors are members of the G protein-coupled receptor superfamily, which together with chemokine ligands form chemokine networks to regulate various cellular functions, immune and physiological processes. These receptors are closely related to cell movement and thus play a vital role in several physiological and pathological processes that require regulation of cell migration. CXCR4, one of the most intensively studied chemokine receptors, is involved in many functions in addition to immune cells recruitment and plays a pivotal role in the pathogenesis of liver disease. Aberrant CXCR4 expression pattern is related to the migration and movement of liver specific cells in liver disease through its cross-talk with a variety of significant cell signaling pathways. An in-depth understanding of CXCR4-mediated signaling pathway and its role in liver disease is critical to identifying potential therapeutic strategies. Current therapeutic strategies for liver disease mainly focus on regulating the key functions of specific cells in the liver, in which the CXCR4 pathway plays a crucial role. Multiple challenges remain to be overcome in order to more effectively target CXCR4 pathway and identify novel combination therapies with existing strategies. This review emphasizes the role of CXCR4 and its important cell signaling pathways in the pathogenesis of liver disease and summarizes the targeted therapeutic studies conducted to date.
- 1 December 2020
- Published by Elsevier in International Immunopharmacology
- Vol. 89, 107067
Chemokine CXCL14 acts as a potential genetic target for liver fibrosis
- 1 December 2020
- Published by Elsevier in International Immunopharmacology
- Vol. 89, 107067
Chemokine CXCL14 acts as a potential genetic target for liver fibrosis
- 10 July 2020
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (2) , 851-862
The role of the CD39–CD73–adenosine pathway in liver disease
Extracellular adenosine triphosphate (ATP) is a danger signal released by dying and damaged cells, and it functions as an immunostimulatory signal that promotes inflammation. The ectonucleotidases CD39/ectonucleoside triphosphate diphosphohydrolase‐1 and CD73/ecto‐5′‐nucleotidase are cell‐surface enzymes that breakdown extracellular ATP into adenosine. This drives a shift from an ATP‐driven proinflammatory environment to an anti‐inflammatory milieu induced by adenosine. The CD39–CD73–adenosine pathway changes dynamically with the pathophysiological context in which it is embedded. Accumulating evidence suggests that CD39 and CD73 play important roles in liver disease as critical components of the extracellular adenosinergic pathway. Recent studies have shown that the modification of the CD39–CD73–adenosine pathway alters the liver's response to injury. Moreover, adenosine exerts different effects on the pathophysiology of the liver through different receptors. In this review, we aim to describe the role of the CD39–CD73–adenosine pathway and adenosine receptors in liver disease, highlighting potential therapeutic targets in this pathway, which will facilitate the development of therapeutic strategies for the treatment of liver disease.
- 10 July 2020
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (2) , 851-862
The role of the CD39–CD73–adenosine pathway in liver disease
Extracellular adenosine triphosphate (ATP) is a danger signal released by dying and damaged cells, and it functions as an immunostimulatory signal that promotes inflammation. The ectonucleotidases CD39/ectonucleoside triphosphate diphosphohydrolase‐1 and CD73/ecto‐5′‐nucleotidase are cell‐surface enzymes that breakdown extracellular ATP into adenosine. This drives a shift from an ATP‐driven proinflammatory environment to an anti‐inflammatory milieu induced by adenosine. The CD39–CD73–adenosine pathway changes dynamically with the pathophysiological context in which it is embedded. Accumulating evidence suggests that CD39 and CD73 play important roles in liver disease as critical components of the extracellular adenosinergic pathway. Recent studies have shown that the modification of the CD39–CD73–adenosine pathway alters the liver's response to injury. Moreover, adenosine exerts different effects on the pathophysiology of the liver through different receptors. In this review, we aim to describe the role of the CD39–CD73–adenosine pathway and adenosine receptors in liver disease, highlighting potential therapeutic targets in this pathway, which will facilitate the development of therapeutic strategies for the treatment of liver disease.
- Open Access
- 5 June 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (23) , e20548
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
Few studies have paid attention to the performances of non-invasive models in diagnosing stages of liver fibrosis and inflammation, which are critical for early and accurate assessment of prognostication and decisions on antiviral treatment in chronic hepatitis B infection patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels (≤2 times upper limit of normal (ULN)). This study aimed to investigate the value of routine serum markers in evaluation of liver inflammation and fibrosis in these patients. A total of 370 consecutive chronic hepatitis B virus-infected patients who underwent liver biopsy were retrospectively analyzed. The Scheuer scoring system was adopted as the pathological standard for diagnosing liver inflammation and fibrosis. The receiver-operating characteristic curves (ROC) and the area under the ROC curves (AUROCs) were used to analyze the performances of the models, including aspartate transaminase to platelet ratio index (APRI), fibrosis index based on the 4 factors (FIB-4), red cell volume distribution width-to-platelet ratio (RPR), globulin-platelet model (GP), and gamma-glutamyl transpeptidase to platelet ratio index (GPR). To predict significant inflammation (G ≥2), the AUROC of APRI was higher than that of FIB-4 (0.705 vs 0.629, P = .001), RPR (0.705 vs 0.593, P < .001) and GP (0.705 vs 0.620, P = .002), equivalent to that of GPR (0.705 vs 0.690, P = .606). As for severe inflammation (≥G3) and significant fibrosis (≥S2), there was no statistic difference among them. To predict severe fibrosis (≥ S3), the AUROC of FIB-4 was higher than that of RPR (0.805 vs 0.750, P = .006) and GP (0.805 vs 0.755, P = .046), comparable to that of APRI (0.805 vs 0.785, P = .550) and GPR (0.805 vs 0.818, P = .694). As for significant liver histological changes (G ≥ 2 or/and S ≥ 2), the performance of APRI was higher than that of RPR (0.717 vs 0.652, P = .006), GP (0.717 vs 0.659, p = .011), equivalent to that of FIB-4 (0.717 vs 0.692, P = .254) and GPR (0.717 vs 0.680, P = .166). We found that APRI, GPR, and FIB-4 were more effective than RPR and GP for diagnosing liver inflammation and fibrosis.
- 5 June 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (23) , e20548
Open AccessComparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
Few studies have paid attention to the performances of non-invasive models in diagnosing stages of liver fibrosis and inflammation, which are critical for early and accurate assessment of prognostication and decisions on antiviral treatment in chronic hepatitis B infection patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels (≤2 times upper limit of normal (ULN)). This study aimed to investigate the value of routine serum markers in evaluation of liver inflammation and fibrosis in these patients. A total of 370 consecutive chronic hepatitis B virus-infected patients who underwent liver biopsy were retrospectively analyzed. The Scheuer scoring system was adopted as the pathological standard for diagnosing liver inflammation and fibrosis. The receiver-operating characteristic curves (ROC) and the area under the ROC curves (AUROCs) were used to analyze the performances of the models, including aspartate transaminase to platelet ratio index (APRI), fibrosis index based on the 4 factors (FIB-4), red cell volume distribution width-to-platelet ratio (RPR), globulin-platelet model (GP), and gamma-glutamyl transpeptidase to platelet ratio index (GPR). To predict significant inflammation (G ≥2), the AUROC of APRI was higher than that of FIB-4 (0.705 vs 0.629, P = .001), RPR (0.705 vs 0.593, P < .001) and GP (0.705 vs 0.620, P = .002), equivalent to that of GPR (0.705 vs 0.690, P = .606). As for severe inflammation (≥G3) and significant fibrosis (≥S2), there was no statistic difference among them. To predict severe fibrosis (≥ S3), the AUROC of FIB-4 was higher than that of RPR (0.805 vs 0.750, P = .006) and GP (0.805 vs 0.755, P = .046), comparable to that of APRI (0.805 vs 0.785, P = .550) and GPR (0.805 vs 0.818, P = .694). As for significant liver histological changes (G ≥ 2 or/and S ≥ 2), the performance of APRI was higher than that of RPR (0.717 vs 0.652, P = .006), GP (0.717 vs 0.659, p = .011), equivalent to that of FIB-4 (0.717 vs 0.692, P = .254) and GPR (0.717 vs 0.680, P = .166). We found that APRI, GPR, and FIB-4 were more effective than RPR and GP for diagnosing liver inflammation and fibrosis.
- 1 December 2019
- Published by Elsevier in International Immunopharmacology
- Vol. 77, 105915
Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation
- 1 December 2019
- Published by Elsevier in International Immunopharmacology
- Vol. 77, 105915
Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation